OVID Clinic Berlin (Compassionate Use)
Berlin, Deutschland
Behandlung & Zugang
- Angebotene Behandlungenpsilocybin
- ZugangswegHärtefallprogramm (Compassionate Use)
- Preise (vom Anbieter veröffentlicht)No price published; psilocybin (PEX010) administered within authorised Expanded Access Programme; treatment embedded in multi-week day-clinic programme (day clinic ca. EUR 15,000 / 6 weeks, PKV usually covers) — wie veröffentlicht, geprüft am 2026-07-27
- Telefon+49 30 257 699 69 (Tagesklinik)
- Websitehttps://ovid-clinics.de
Verwandte Einträge
Diese Einträge gehören zur selben Organisation. Sie werden separat geführt, weil jeder ein eigenes Programm oder ein eigener Standort ist.
- Weiteres Programm an dieser KlinikOVID Clinic Berlin — Ketamin / KAP
Über diesen Anbieter
Compassionate-use arm of OVID Clinics Berlin: under the direction of Prof. Dr. Gerhard Gruender, individual adult patients with treatment-resistant depression can receive psilocybin (PEX010, Filament Health) at the OVID day clinic in Berlin within Germany's first authorised Expanded Access (Compassionate Use) Programme, run jointly with the Central Institute of Mental Health (ZI) Mannheim since July 2025. It is not a regular therapy offer: eligibility requires a serious illness, no satisfactory approved treatment and no possibility of trial participation, with case-by-case benefit-risk review.
Leistungen & Programme
- Psilocybin single-dose treatment with accompanying psychotherapy (preparation and follow-up), within multi-week day-clinic setting
Programme & Studien
| Programm | Art | Status |
|---|---|---|
| Psilocybin Expanded Access Programme for treatment-resistant depression (with ZI Mannheim; PEX010 / Filament Health) | active since 11 July 2025; exceptional cases only |
Ausstattung & Sprachen
- Ausstattung
- OVID Tagesklinik, Boxhagener Str. 82, Berlin
- SprachenGerman, English, Spanish, Turkish (clinic-wide)
- TeamProf. Dr. med. Gerhard Gruender (programme director, licence holder); Dr. med. Andrea Jungaberle (holds OVID's psilocybin treatment licence)
Häufige Fragen
Can I apply for psilocybin treatment?
Only in justified exceptional cases: adults with treatment-resistant depression, no satisfactory approved treatment available, and participation in a clinical trial not possible; each case undergoes benefit-risk review.
Is the programme a route to regular psilocybin therapy?
No. ZI/OVID state the Compassionate Use Programme cannot replace regulatory approval and that demand will significantly exceed capacity.
Verifizierung
- Lizenz / RegisterÖffentliches Studienregister (ClinicalTrials.gov / EU CTIS)
- Quellehttps://ovid-clinics.de
- Zuletzt verifiziert